Stablepoint Partners, LLC Iqvia Holdings Inc. Transaction History

Stablepoint Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$137.0 - $174.37 $55,211 - $70,271	-403 Reduced 6.76%	5,556 $876 Million
Q1 2025 Apr 11, 2025	BUY	$176.3 - $209.96 $1,586 - $1,889	9 Added 0.15%	5,959 $1.05 Billion
Q4 2024 Jan 21, 2025	BUY	$190.97 - $236.63 $95,485 - $118,315	500 Added 9.17%	5,950 $1.17 Billion
Q3 2024 Oct 11, 2024	BUY	$206.81 - $251.55 $26,471 - $32,198	128 Added 2.41%	5,450 $1.29 Billion
Q2 2024 Aug 02, 2024	BUY	$211.18 - $248.87 $95,242 - $112,240	451 Added 9.26%	5,322 $1.26 Billion

Q1 2024 Apr 23, 2024	BUY	$208.23 - $259.1 $244,878 - $304,701	1,176 Added 31.83%	4,871 $1.23 Billion
Q4 2023 Feb 12, 2024	BUY	$177.16 - $232.73 $654,606 - $859,937	3,695 New	3,695 $855 Million

1,146

160M

2.51M

1.18M

Ticker IQV
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 185,740,000
Market Cap $41B
Description
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The ...

Get notified when there are updates to the investment portfolio of Stablepoint Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Stablepoint Partners, LLC with notifications on news.